A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

December 31, 2004

Conditions

SchizophreniaHepatic Impairment

Interventions

DRUG

Intermediate release (IR) Paliperidone

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00791284 - A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function | Biotech Hunter | Biotech Hunter